Tech Company Financing Transactions
Signadori Bio Funding Round
Sofinnova Partners joined a capital raise for Signadori Bio. The financing round was recorded on 3/19/2025.
Transaction Overview
Company Name
Announced On
3/19/2025
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Paris, Undisclosed
France
Paris, Undisclosed
France
Phone
Undisclosed
Email Address
Not Recorded
Overview
Signadori Bio is a preclinical stage biopharmaceutical company developing an innovative cell therapy approach to treat cancer. The proprietary platform developed by Signadori comes from Institut Gustave Roussy a world leading oncology center. Signadori is based in Paris, France.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Matthieu Coutet
Browse more venture capital transactions:
Prev: 3/19/2025: Spangle venture capital transaction
Next: 3/20/2025: Magenta Mobility venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries reported here are derived from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs